Direkt zum Inhalt
Merck
  • Transcriptomic and proteomic analyses reveal key innate immune signatures in the host response to the gastrointestinal pathogen Campylobacter concisus.

Transcriptomic and proteomic analyses reveal key innate immune signatures in the host response to the gastrointestinal pathogen Campylobacter concisus.

Infection and immunity (2014-12-10)
Nadeem O Kaakoush, Nandan P Deshpande, Si Ming Man, Jose A Burgos-Portugal, Faisal A Khattak, Mark J Raftery, Marc R Wilkins, Hazel M Mitchell
ZUSAMMENFASSUNG

Pathogenic species within the genus Campylobacter are responsible for a considerable burden on global health. Campylobacter concisus is an emergent pathogen that plays a role in acute and chronic gastrointestinal disease. Despite ongoing research on Campylobacter virulence mechanisms, little is known regarding the immunological profile of the host response to Campylobacter infection. In this study, we describe a comprehensive global profile of innate immune responses to C. concisus infection in differentiated THP-1 macrophages infected with an adherent and invasive strain of C. concisus. Using RNA sequencing (RNA-seq), quantitative PCR (qPCR), mass spectrometry, and confocal microscopy, we observed differential expression of pattern recognition receptors and robust upregulation of DNA- and RNA-sensing molecules. In particular, we observed IFI16 inflammasome assembly in C. concisus-infected macrophages. Global profiling of the transcriptome revealed the significant regulation of a total of 8,343 transcripts upon infection with C. concisus, which included the activation of key inflammatory pathways involving CREB1, NF-κB, STAT, and interferon regulatory factor signaling. Thirteen microRNAs and 333 noncoding RNAs were significantly regulated upon infection, including MIR221, which has been associated with colorectal carcinogenesis. This study represents a major advance in our understanding of host recognition and innate immune responses to infection by C. concisus.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Acetonitril, suitable for HPLC, gradient grade, ≥99.9%
Sigma-Aldrich
Acetonitril, HPLC Plus, ≥99.9%
Sigma-Aldrich
Natriumbicarbonat, ACS reagent, ≥99.7%
Sigma-Aldrich
Natriumbicarbonat, powder, BioReagent, for molecular biology, suitable for cell culture, suitable for insect cell culture
Sigma-Aldrich
Acetonitril, ACS reagent, ≥99.5%
Sigma-Aldrich
Phorbol-12-myristat-13-acetat, ≥99% (TLC), film or powder
Sigma-Aldrich
Natriumbicarbonat, ReagentPlus®, ≥99.5%, powder
Sigma-Aldrich
Jodacetamid, Single use vial of 56 mg
Sigma-Aldrich
Acetonitril, suitable for HPLC, gradient grade, ≥99.9%
Sigma-Aldrich
Jodacetamid, BioUltra
Sigma-Aldrich
L-Glutamin, meets USP testing specifications, suitable for cell culture, 99.0-101.0%, from non-animal source
Sigma-Aldrich
Natriumpyruvat, powder, BioReagent, suitable for cell culture, suitable for insect cell culture, ≥99%
Sigma-Aldrich
Jodacetamid, ≥99% (NMR), crystalline
Sigma-Aldrich
L-Glutamin, ReagentPlus®, ≥99% (HPLC)
Sigma-Aldrich
Natriumbicarbonat, anhydrous, free-flowing, Redi-Dri, ACS reagent, ≥99.7%
SAFC
L-Glutamin
Sigma-Aldrich
Natriumbicarbonat, puriss., meets analytical specification of Ph. Eur., BP, USP, FCC, E500, 99.0-100.5%, powder
Sigma-Aldrich
L-Threonin, from non-animal source, meets EP, JP, USP testing specifications, suitable for cell culture, 99.0-101.0%
Sigma-Aldrich
Acetonitril, biotech. grade, ≥99.93%
Sigma-Aldrich
Natriumpyruvat, Hybri-Max, powder, suitable for hybridoma
Sigma-Aldrich
Phorbol-12-myristat-13-acetat, synthetic, ≥98.0% (TLC)
Sigma-Aldrich
Natriumpyruvat, powder, BioXtra, suitable for mouse embryo cell culture
Sigma-Aldrich
L-Glutamin, BioUltra, ≥99.5% (NT)
Sigma-Aldrich
Acetonitril, anhydrous, 99.8%
SAFC
L-Threonin
Sigma-Aldrich
Aphidicolin, ≥98% (HPLC), powder
USP
Natriumbicarbonat, United States Pharmacopeia (USP) Reference Standard
SAFC
Jodacetamid
Sigma-Aldrich
Acetonitril, electronic grade, 99.999% trace metals basis
Sigma-Aldrich
Acetonitril, ReagentPlus®, 99%